Clinical Studies

Alzheimer’s and Memory Loss Clinical Studies

Have you been diagnosed with Alzheimer’s? Do you want to partner in the kind of research that can give your grandchildren greater access to more effective treatment options? Maybe you’d like to be a part of finding a cure?

We’re partnering with patients like you on groundbreaking research to help doctors and caregivers treat and care for those affected by Alzheimer’s disease today, as well as those who come after us.

We’d love to partner with you.

Schedule Your Assessment

Your contact information

Do you live in Central Florida?

Preferred Charter Research location

I would like to receive the Charter Research newsletter.

I would like to receive text messages from Charter Research for communication purposes.

Comments (not required)

This field is for validation purposes and should be left unchanged.

Types of Studies

What studies are available?

Below you’ll find the clinical trials that we’re currently enrolling patients in or will be soon.

View All Open Studies

Alzheimer’s Detection Study
The purpose of this end-of-life study is to evaluate the effectiveness of a new brain (PET) scan in accurately detecting Alzheimer’s disease. We hope that earlier, more accurate detection of Alzheimer’s disease will one day allow patients to confirm their diagnosis more easily, and then they can confidently begin new treatments that may delay—or eventually even reverse—the progression of the disease.
Early Alzheimer’s Study
The purpose of this early-Alzheimer's study is to find out if the study drug can possibly prevent, delay, or slow early symptoms of Alzheimer’s disease. It is thought this new investigational drug may help the blood vessels in your brain work better by increasing blood flow to the brain, reducing inflammation, and possibly curtailing amyloid protein production, a major biomarker for Alzheimer's.
Sensory Stimulation Alzheimer’s Study
The main purpose of this study is to see whether daily use of a device—called the "Sensory Stimulation System"—can help people with Alzheimer's-related memory problems. The device provides sensory stimulation via glasses worn on the face and headphones worn over the ears.
“Healthy” Alzheimer’s Study
If you're healthy, but worried that your memory might start fading, then joining an Alzheimer's prevention study might be a great option for you. It might just help future generations too. This study examines whether a new drug may help to slow or prevent the onset of Alzheimer's disease in those with elevated risk of developing the disease.
Dopamine Alzheimer’s Study
Patients with mild to moderate Alzheimer’s disease often have negative changes in their dopamine levels, as well as changes to how their bodies process dopamine. This can lead to adverse changes in personality, mood, and behavior. This investigational drug enhances the body’s ability to utilize dopamine.
Early Alzheimer’s Combination Therapy Study
You may have heard about lecanemab (Leqembi) in the news over the past year, that it is one of the latest FDA-approved drugs to help in the fight against Alzheimer’s. Did you know that even though drugs like this are approved for the public, pharmaceutical companies continue to research their benefits? This study looks at […]

Commitment to Your Care

Who will I be working with?

Participating in a clinical trial can feel intimidating at first. Put your mind at ease by getting to know some of our caring experts who’ll be working with you every step of the way.

Learn more about our Commitment to Care

Jeffrey Norton, MD, CPI
Medical Director, The Villages
Leading our research center in The Villages, Florida, Dr. Jeffrey Norton has more than 20 years of experience in anesthesiology and pain management and has served...
Edgardo Rivera, MD, FACEP
Medical Director, Orlando
Leading our research center in Orlando, Florida, Dr. Edgardo Rivera has served as Principal Investigator or Sub-Investigator on more than 40 clinical trials across all...
Stephen Miller, MD
Principal Investigator
Dr. Stephen Miller has over 15 years of diverse clinical and healthcare policy experience and has served as an investigator on more than 20 clinical...
Diana Balsalobre, MD
Principal Investigator
Dr. Diana Balsalobre is a Board-Certified Neurologist with over 22 years of clinical experience.  She completed her Internship and Neurology Residency in Jackson Memorial Hospital...
Mary Quarterman, MD
Principal Investigator
Dr. Mary Quarterman is an established and highly skilled physician with over 13 years of experience.  Dr. Quarterman received her medical degree from Florida State...
Ramon Rodriguez, MD
Principal Investigator
Dr. Ramon Rodriguez is a board certified Neurologist and highly experienced Principal Investigator. Dr. Rodriguez received his medical degree (M.D.) from the University of Puerto...

Our Promise to You

What resources do you have for me?

We regularly share insights, tips, and new discoveries to provide you the latest on the diseases and chronic conditions you’re living with.

See all resources

Can You Reverse Mild Cognitive Impairment?
Nearly one in five Americans over the age of 60 experience subtle downturns in memory, thinking, and cognition. Clinically, this fading of cognitive abilities is...
The lesser-known problematic protein wreaking havoc on the brain: TDP-43
Scientists have linked the progression of Alzheimer’s to the buildup of certain kinds of protein in the brain, which malfunction and gum up communication between...
Could Drugs for Other Diseases Be the Answer to Treating Alzheimer’s?
Asthma drugs, cancer drugs, even obesity drugs, are all being explored for their potential in treating the pathology and symptoms of Alzheimer’s disease. Finding the...
Why Women Are More Likely to Develop Alzheimer’s
Research has established that women are twice as likely to develop Alzheimer’s, but despite study after study into this sex-based disparity in Alzheimer’s risk, scientists...
Managing Symptoms in the Later Stages of Alzheimer’s
Symptom management in Alzheimer’s helps people remain independent for longer. Alzheimer’s disease is a progressive neurodegenerative condition that affects more than one in every 9...
A Pill For Alzheimer’s? Alzheon Starts Clinical Trials
Charter Research is recruiting for a new Phase 3 trial for Alzheon’s new drug, which aims to be the first oral disease-modifying therapy for Alzheimer’s....